Currently, traditional tumor markers, such as carcinoembryonic antigen (CEA) and cytokeratin 19 fragment (CYFRA 21-1), are used to diagnose and evaluate ESCC progression but their sensitivity and validity are insufficient for early ESCC detection [44]. The gene discussed is CEACAM5; the disease is esophageal squamous cell carcinoma.